AUD 0.03
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 8.75 Million AUD | -2.97% |
2023 | 9.02 Million AUD | 166.56% |
2022 | 3.38 Million AUD | -53.03% |
2021 | 7.2 Million AUD | 896.05% |
2020 | 723.51 Thousand AUD | -51.91% |
2019 | 1.5 Million AUD | -61.86% |
2018 | 3.94 Million AUD | 2.61% |
2017 | 3.84 Million AUD | 181.55% |
2016 | 1.36 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 4.82 Million AUD | 0.0% |
2024 Q2 | 2.98 Million AUD | 0.0% |
2024 FY | 8.76 Million AUD | -2.89% |
2023 FY | 9.02 Million AUD | 166.56% |
2023 Q2 | 2.7 Million AUD | 0.0% |
2023 Q4 | 4.29 Million AUD | 0.0% |
2022 Q2 | 1.63 Million AUD | 0.0% |
2022 FY | 3.38 Million AUD | -53.03% |
2022 Q4 | 3.11 Million AUD | 0.0% |
2021 FY | 7.2 Million AUD | 896.05% |
2021 Q4 | 3.74 Million AUD | 0.0% |
2021 Q2 | 3.46 Million AUD | 0.0% |
2020 Q4 | 284.25 Thousand AUD | 0.0% |
2020 FY | 723.51 Thousand AUD | -51.91% |
2020 Q2 | 439.26 Thousand AUD | 0.0% |
2019 Q2 | 806.58 Thousand AUD | 0.0% |
2019 Q4 | 741.22 Thousand AUD | 0.0% |
2019 FY | 1.5 Million AUD | -61.86% |
2018 Q4 | 1.99 Million AUD | 0.0% |
2018 FY | 3.94 Million AUD | 2.61% |
2018 Q2 | 1.94 Million AUD | 0.0% |
2017 Q4 | 1.84 Million AUD | 0.0% |
2017 Q2 | 1.99 Million AUD | 0.0% |
2017 FY | 3.84 Million AUD | 181.55% |
2016 Q2 | 676.62 Thousand AUD | 100.0% |
2016 Q1 | 338.31 Thousand AUD | 0.0% |
2016 Q3 | - AUD | -100.0% |
2016 FY | 1.36 Million AUD | 0.0% |
2016 Q4 | 2.2 Million AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 72.194% |
Adherium Limited | 267.7 Thousand AUD | -3170.153% |
Aroa Biosurgery Limited | 66.09 Million AUD | 86.756% |
Atomo Diagnostics Limited | 1.6 Million AUD | -445.098% |
Anteris Technologies Ltd | 69.14 Million AUD | 87.34% |
Control Bionics Limited | 9.82 Million AUD | 10.906% |
CardieX Limited | 16.64 Million AUD | 47.418% |
Compumedics Limited | 26.88 Million AUD | 67.432% |
Cochlear Limited | 1.17 Billion AUD | 99.255% |
CleanSpace Holdings Limited | 11.35 Million AUD | 22.933% |
Cyclopharm Limited | 13.38 Million AUD | 34.576% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 31.786% |
Nova Eye Medical Limited | 23.99 Million AUD | 63.509% |
HeraMED Limited | 6.78 Million AUD | -29.063% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 884.548% |
ImpediMed Limited | 28.04 Million AUD | 68.78% |
InhaleRx Limited | 2.59 Million AUD | -237.934% |
LBT Innovations Limited | 1.1 Million AUD | -690.813% |
Micro-X Limited | 18.76 Million AUD | 53.345% |
OncoSil Medical Limited | 12.03 Million AUD | 27.289% |
PolyNovo Limited | 34.92 Million AUD | 74.932% |
Respiri Limited | 8.03 Million AUD | -8.954% |
SomnoMed Limited | 58.97 Million AUD | 85.155% |
Universal Biosensors, Inc. | 20 Million AUD | 56.229% |
Uscom Limited | 5.52 Million AUD | -58.591% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 9.128% |